SK
Subha Kulandai Velu
About Subha Kulandai Velu
Data last updated:
Subha Kulandai Velu is a Director at Apollo Dialysis Private Limited (since 2014), Additional Director at Neuberg Ajay Shah Laboratory Private Limited (since 2026) and Additional Director at Trivitech Enterprises Private Limited (since 2025), and holds 13 more current directorships. The companies operate in Healthcare, Financial Services and Real Estate and Construction. The 11 current companies with reported revenue have a combined latest revenue of ₹207 Cr; the largest is Apollo Dialysis Private Limited at ₹129 Cr (FY 2026). Earlier, Subha Kulandai Velu was a Director at Trivitron Healthcare Private Limited (1998–2025) and Nominee Director at Neuberg Ehrlich Laboratory Private Limited (2019–2024) and 15 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Mar 2014 | 2014 | ₹129 Cr (FY 2026) | Active | |
| Additional Director | 31 Jan 2026 | 2020 | ₹29.52 Cr (FY 2025) | Active | |
| Additional Director | 30 Jun 2025 | 1997 | ₹15.11 Cr (FY 2022) | Active | |
| Director | 25 Apr 2024 | 2013 | ₹14.36 Cr (FY 2024) | Active | |
| Additional Director | 23 Jan 2026 | 2021 | ₹11.32 Cr (FY 2025) | Active | |
| Director | 18 Jan 2024 | 2022 | ₹3.53 Cr (FY 2025) | Active | |
| Director | 31 Aug 2024 | 2021 | ₹2.71 Cr (FY 2024) | Active | |
| Director | 09 Dec 2023 | 2016 | ₹90 Lakh (FY 2022) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 May 1998 | 1998 | ₹497 Cr (FY 2024) | Active | |
| Nominee Director | 28 Oct 2019 | 1979 | ₹94.56 Cr (FY 2025) | Active | |
| Director | 15 Apr 2010 | 2010 | ₹404 Cr (FY 2025) | Active | |
| Director | 01 Jul 2022 | 2022 | ₹35.84 Cr (FY 2025) | Active | |
| Director | 05 Oct 2017 | 2017 | ₹853 Cr (FY 2025) | Active | |
| Director | 04 Jul 2003 | 2003 | Amalgamated | ||
| Director | 25 Aug 2007 | 2005 | ₹17.17 Cr (FY 2022) | Active | |
| Director | 27 Jan 2016 | 2016 | ₹9.5 Lakh (FY 2018) | Amalgamated | |
| Director | 13 Aug 2001 | 2001 | Amalgamated | ||
| Director | 16 Jun 2008 | 2008 | Strike Off | ||
| Director | 12 Oct 1999 | 1999 | Amalgamated | ||
| Director | 01 Apr 2016 | 2016 | Amalgamated | ||
| Director | 12 Jun 2008 | 2008 | Amalgamated | ||
| Director | 02 Dec 2010 | 2010 | Strike Off | ||
| Director | 25 Aug 2008 | 2008 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Subha Kulandai Velu
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subha Kulandai Velu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subha Kulandai Velu
Subha Kulandai Velu currently holds 16 directorships: Apollo Dialysis Private Limited (Director, since 20 Mar 2014, revenue ₹129 Cr (FY 2026)); Neuberg Ajay Shah Laboratory Private Limited (Additional Director, since 31 Jan 2026, revenue ₹29.52 Cr (FY 2025)); Trivitech Enterprises Private Limited (Additional Director, since 30 Jun 2025, revenue ₹15.11 Cr (FY 2022)); Neuberg Magnum Imaging & Diagnostics Private Limited (Director, since 25 Apr 2024, revenue ₹14.36 Cr (FY 2024)); Neuberg Sehgal Path Lab Private Limited (Additional Director, since 23 Jan 2026, revenue ₹11.32 Cr (FY 2025)); and 11 more.
Subha Kulandai Velu was first appointed on 18 May 1998 as Director at Trivitron Healthcare Private Limited. The most recent appointment on record is 31 Jan 2026 at Neuberg Ajay Shah Laboratory Private Limited.
The 11 current companies of Subha Kulandai Velu that report revenue have a combined latest revenue of ₹207 Cr: Apollo Dialysis Private Limited ₹129 Cr (FY 2026); Neuberg Ajay Shah Laboratory Private Limited ₹29.52 Cr (FY 2025); Trivitech Enterprises Private Limited ₹15.11 Cr (FY 2022); Neuberg Magnum Imaging & Diagnostics Private Limited ₹14.36 Cr (FY 2024); Neuberg Sehgal Path Lab Private Limited ₹11.32 Cr (FY 2025); and 6 more.
Subha Kulandai Velu held 17 earlier board appointments: Trivitron Healthcare Private Limited (Director, 18 May 1998 to 12 Mar 2025); Neuberg Ehrlich Laboratory Private Limited (Nominee Director, 28 Oct 2019 to 28 Jun 2024); Maxivision Eye Hospitals Private Limited (Director, 15 Apr 2010 to 11 Jun 2024); Netradeep Maxivision Eye Hospitals Private Limited (Director, 01 Jul 2022 to 12 Jul 2023); Neuberg Diagnostics Private Limited (Director, 05 Oct 2017 to 14 Jul 2023); and 12 more.
The current boards of Subha Kulandai Velu's companies include Akhileswaran Krishnan (Apollo Dialysis Private Limited), Chandra Sekhar Chivukula (Apollo Dialysis Private Limited), Gomathy Babu Sadacharam Kulandaivelu (Apollo Dialysis Private Limited), Narotham Guruvari Reddy (Apollo Dialysis Private Limited), Sindoori Reddy (Apollo Dialysis Private Limited), Sriram Srinivasan Iyer (Apollo Dialysis Private Limited), among others.